| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | +46.4% |
| Cost of Revenue | $1.5M | +19.0% |
| Gross Profit | $299K | +886.8% |
| R&D Expense | $1.7M | +97.0% |
| SG&A Expense | $5.9M | +100.5% |
| Operating Income | -$10.1M | -79.3% |
| Net Income | -$10.1M | -18.9% |
| EPS (Basic) | -$1.04 | +57.2% |
| EPS (Diluted) | -$1.04 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -72.9% |
| Accounts Receivable | $88K | -4.3% |
| Inventory | $863K | +101.2% |
| Current Assets | $5.3M | -63.0% |
| Total Assets | $5.9M | -61.1% |
| Current Liabilities | $1.9M | +52.5% |
| Total Liabilities | $2.2M | +26.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.9M | -58.9% |
| Capital Expenditures | $11K | — |
| Investing Cash Flow | -$11K | — |
| Financing Cash Flow | -$528K | -103.0% |
| Free Cash Flow | -$8.9M | — |
| +57.2% |
| Stockholders' Equity |
| $3.6M |
| -72.6% |